Actively Recruiting
Treatment of Low-Flow Venous Malformations Using Electrosclerotherapy A Prospective Observational Study with Bleomycin Infusion
Led by Istituto Ortopedico Rizzoli · Updated on 2026-05-22
65
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Venous malformations are congenital abnormalities in the veins caused by developmental errors during embryogenesis, featuring large venous-like spaces. This research is an observational study evaluating the use of electrosclerotherapy with bleomycin, a drug commonly used as a sclerosing agent for slow-flow vascular malformations, due to its lower risk of serious local side effects compared to other treatments. The study is sponsored by Istituto Ortopedico Rizzoli and focuses on patients with low-flow venous malformations. The treatment involves applying electroporation to deliver bleomycin directly into the lesion. All patients who undergo electrosclerotherapy for vascular malformations are included in the study. This method is less invasive and aims to reduce the volume of the malformations, as well as improve pain and quality of life over time. Participants will be monitored for one year to assess the reduction in volume of the malformations, changes in pain using a visual analog scale, and improvements in quality of life through the EuroQol-5D questionnaire. The study does not include randomization or blinding, and the total time commitment depends on the treatment schedule and follow-up assessments during this period.
CONDITIONS
Brief Title
Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational Study
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here